Tech Company Financing Transactions

Ra Pharmaceuticals Funding Round

Lightstone Ventures, Novo Ventures and RA Capital participated in a $58.5 million Series B funding round for Ra Pharmaceuticals. The financing round was recorded on 7/23/2015.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

87 Cambridge Park Dr.
Cambridge, MA 02140
USA

Phone

(617) 401-4060

Website

www.rapharma.com

Email Address

[email protected]

Overview

Ra Pharmaceuticals is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma's peptide-like molecules are highly-stable, synthetic products with chemical structures that offer intrinsic cell permeability.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Doug Treco

        

Chief Financial Officer

David Lubner

        

Chief Medical Officer

Ramin Farzaneh-Far

        

Chief Scientific Officer

Simon Read

        

VP - R & D

Alonso Ricardo

        

Browse more venture capital transactions:

Prev: 7/23/2015: VoltDB venture capital transaction
Next: 7/23/2015: MedGenome venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary